Skip to content
20-F/A

Annual Report (Foreign)

BioLineRx Ltd. BLRX

0001178913-26-001807

← back to feed
Filed
Mar 27, 2026 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 8, 2026 2.61B sh